XCUR EXICURE INC

-

EXICURE INC Reported Earnings

Friday, August 14, 2026 · 12:00 AM ET

EXICURE INC (XCUR) reported a loss of $0.18 per share on revenue of $0.00 million for the . .

Exicure Inc. is a clinical-stage biotechnology company. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Exicure Inc. is based in IL, United States.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.18)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth56.1 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth